Great visit to @IrcadFrance & bump into Jacques Marescaux.
Amazing centre showcasing >50 🤖 systems & valuable hands-on experience with the @MicroPort@MedBotSurgical Toumai System alongside @MMoghul & upper GI colleagues — exciting to see where robotic surgery is heading.
A cost-analysis and micro-costing study of the Man Van Project: Comparing prostate-specific antigen testing via a nurse-led mobile service with primary care. #AuthorCommentary@MMoghul@royalmarsdenNHS discusses recent findings from a report which sought to examine not only financial implications, but also the broader service delivery considerations that influence access to prostate cancer screening. #ReadNow > https://t.co/mgMJkuTuFY @ICR_London #PharmacoEconomics
Delighted that our newest 🤖 consultant @MMoghul has been appointed to the @ProstateUK Prostate Cancer Clinical Research Strategy Group. Great to see @geshNHS, @croydonhealth and @SWLNHS network help shaping the future direction of prostate cancer research in the UK 👏🔬
Today @CalvinBailey, @HelenMorganMP and @RishiSunak handed in a letter to @wesstreeting, signed by 125 MPs, calling for targeted prostate cancer screening for men at highest risk.
More details at: https://t.co/kARUVqcx2b
Congrats to @MMoghul on successfully completing our @RCSnews accredited 🤖 fellowship. 217 Procedures, 62 RARPs (6 solo unsupervised) & plenty of Cystectomy, Renal & Recon 🤖 culminating in a locum pelvic onc consultant appointment @geshNHS. Over to you @Dr_MayankAg#fellowship
Congrats to our @IntuitiveSurg@RCSnews 🤖 Fellow & Consultant colleague @MMoghul on completing his first solo 🤖 assisted radical prostatectomy for #prostatecancer. Onwards and upwards 🙌. Keep an 👁 out for Oct 2026 Post CCT Fellowship advert @geshNHS this winter!
It was great to talk to @MMoghul at @ASCO#GU25 on the Man Van trial, which introduces mobile #prostatecancer testing, and how it'll testing tackle health inequalities
Visit https://t.co/ys1d8pE8Am to see who we've interviewed so far!
#pcsm#uroonc@OncoAlert
#Movember
The Man Van🚐 by @royalmarsdenNHS and @ICR_London is making early #ProstateCancer detection accessible for men in underserved communities. This new study by @MMoghul et al. shows how it is a game changer in healthcare access
🔓➡️ https://t.co/pYtDRBLgwe
@uicc
Offering prostate cancer checks via a “Man Van” at football matches is more effective and cheaper than relying on GPs, according to a report ⬇️ https://t.co/VE5PBgECcJ
Man Van pilot outcomes on BBC and @thetimes this morning as well. Our economic analysis shows is excellent value for money. Points the way to health outreach in areas with poorer outcomes, complementary to GP services. @ICR_London@RMPartnersNHS@royalmarsden@royalmarsdenNHS
The Man Van: A pilot study of using mobile targeted case-finding to address health inequalities in prostate cancer out on International Journal of Cancer by @Prof_Nick_James and team
https://t.co/1EivizqwEG
The Man Van 🚍project was developed to improve early detection of #ProstateCancer and other health conditions among high-risk men from deprived communities and ethnic minorities, who face barriers to healthcare access🚧
From December 2021 to December 2022, the project was piloted in 8⃣ locations with a focus on areas with high deprivation and minority populations. Of the 610 men who attended, 48% were non-White, with 30% being Black. Prostate cancer was diagnosed in 3.6% of attendees, with Black men having a higher diagnosis rate than White men
The project demonstrated the effectiveness of the mobile health model in reducing healthcare inequalities, diagnosing prostate cancer at earlier stages, and identifying other health conditions.
@MMoghul@JanetteKinsella@CahillDeclan@ICR_London@RMPartnersNHS@royalmarsdenNHS
Our paper on the Pilot Phase of the Man Van project now out. High rates of prostate cancer detection in area of high deprivation. Plus other pathology - diabetes and hypertension especially. @ICR_London@RMPartnersNHS@royalmarsdenNHS@MMoghul https://t.co/plF0Y7nSza